Ubs Oconnor LLC Third Harmonic Bio, Inc. Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 52,294 shares of THRD stock, worth $674,592. This represents 0.05% of its overall portfolio holdings.

Number of Shares

52,294

Holding current value

$674,592

% of portfolio

0.05%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.86 - $15.0 $33,046 - $45,645	3,043 Added 6.18%	52,294 $708,000
Q2 2024 Aug 14, 2024	BUY	$8.74 - $15.54 $7,411 - $13,177	848 Added 1.75%	49,251 $640,000
Q1 2024 May 15, 2024	SELL	$8.6 - $11.24 $140,188 - $183,223	-16,301 Reduced 25.19%	48,403 $456,000
Q4 2023 Feb 14, 2024	SELL	$5.97 - $11.47 $359,967 - $691,595	-60,296 Reduced 48.24%	64,704 $709,000
Q3 2023 Nov 14, 2023	BUY	$4.92 - $7.09 $615,000 - $886,250	125,000 New	125,000 $798,000

Others Institutions Holding THRD

# of Institutions

Shares Held

43.6M

Call Options Held

7.1K

Put Options Held

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$141 Million
18.24% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$74.6 Million
1.85% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$56.3 Million
1.88% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$41.1 Million
1.87% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$38.2 Million
1.15% of portfolio

View Full List

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $520M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account